撤回声明。“弥漫性大 B 细胞淋巴瘤的免疫组织化学预后标志物：组织微阵列验证作为广泛临床应用的前提 (来自 Lunenburg 淋巴瘤生物标志物联盟的研究)”（《临床病理学杂志》2009 年；62：128-38；doi：10.1136/jcp.2008.057257）。
Retraction. "Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)" (J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257).
出版信息
J Clin Pathol. 2012 Sep;65(9):861-2. doi: 10.1136/jcp.2008.057257ret.
The Journal of Clinical Pathology wishes to inform its readers of the authors' retraction of the following article for redundancy. The original article by D de Jong, W Xie, Rosenwald, M Chhanabhai, P Gaulard,W Klapper, A Lee, B Sander, C Thorns,E Campo, T Molina, A Hagenbeek,S Horning, A Lister, J Raemaekers, G Salles, R D Gascoyne and E Weller entitled "Immunohistochemical prognostic markersi n diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)" (J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257) published online on 15 September 2008, contained substantial overlap in text, data, and conclusions compared with a previous article with the same title published in Journal of Clinical Oncology on 1 March 2007 by Daphne de Jong, Andreas Rosenwald, Mukesh Chhanabhai, Philippe Gaulard,Wolfram Klapper, Abigail Lee, Birgitta Sander, Christoph Thorns, Elias Campo, Thierry Molina, Andrew Norton, Anton Hagenbeek, Sandra Horning, Andrew Lister, John Raemaekers, Randy D Gascoyne, Gilles Salles and Edie Weller (doi:10.1200/JCO.2006.09.4490). In addition, the authors did not cite the Journal of Clinical Oncology article in the paper published in Journal of Clinical Pathology.
《临床病理学杂志》谨通知其读者，该杂志已撤回以下文章，原因是内容重复。原始文章由 D. de Jong、W. Xie、Rosenwald、M. Chhanabhai、P. Gaulard、W. Klapper、A. Lee、B. Sander、C. Thorns、E. Campo、T. Molina、A. Hagenbeek、S. Horning、A. Lister、J. Raemaekers、G. Salles 和 E. Weller 撰写，题为“弥漫性大 B 细胞淋巴瘤的免疫组织化学预后标志物：组织微阵列的验证是广泛临床应用的前提（来自 Lunenburg 淋巴瘤生物标志物联盟的研究）”（J Clin Pathol 2009;62:128–38;doi:10.1136/jcp.2008.057257），于 2008 年 9 月 15 日在线发表，与同年 3 月 1 日发表在《临床肿瘤学杂志》上的标题相同的先前文章在文本、数据和结论方面存在大量重叠，该先前文章由 Daphne de Jong、Andreas Rosenwald、Mukesh Chhanabhai、Philippe Gaulard、Wolfram Klapper、Abigail Lee、Birgitta Sander、Christoph Thorns、Elias Campo、Thierry Molina、Andrew Norton、Anton Hagenbeek、Sandra Horning、Andrew Lister、John Raemaekers、Randy D. Gascoyne、Gilles Salles 和 Edie Weller 撰写（doi:10.1200/JCO.2006.09.4490）。此外，作者在发表于《临床病理学杂志》的论文中并未引用《临床肿瘤学杂志》的文章。
Zotero 插件